Skye acquires Bird Rock Bio, weeks after Novo Nordisk says it will buy a CB1 developer

Skye Bioscience acquired Bird Rock Bio to get its hands on an asset targeting CB1 just two weeks after Novo Nordisk dipped its toes into the …

Read More at Source.

Pumilo
Author: Pumilo